Merck KGaA Completes Sale of Surface Solutions to GNMI for €665 Million, Launches New Brand Susonity

Reuters
Aug 01
<a href="https://laohu8.com/S/MKGAF">Merck KGaA</a> Completes Sale of Surface Solutions to GNMI for €665 Million, Launches New Brand Susonity

Merck KGaA, Darmstadt, Germany, has announced the successful closure of its divestment of the global Surface Solutions business to Global New Material International Holdings Ltd. (GNMI) for €665 million. With the completion of this transaction, approved by all relevant regulatory authorities, Merck KGaA aims to further sharpen its focus on technology-driven core businesses. The Surface Solutions business will now operate under GNMI as the new Susonity brand. Merck KGaA plans to use the proceeds from this sale to strengthen its strategic core areas while retaining ownership of the property at the Gernsheim site, which will be leased to GNMI on a long-term basis.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Merck KGaA published the original content used to generate this news brief on August 01, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10